Pharmaceutically acceptable salt and crystal form of tetrahydronaphthalene derivative, and preparation method
US-2026098027-A1 · Apr 9, 2026 · US
Shanghai hengrui pharmaceutical co ltd holds 285 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 285 |
| Recent patents | 84 |
| First publication | Sep 15, 2016 |
| Latest publication | Apr 9, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026098027-A1 · Apr 9, 2026 · US
US-2026055088-A1 · Feb 26, 2026 · US
US-12559539-B2 · Feb 24, 2026 · US
US-12559488-B2 · Feb 24, 2026 · US
US-2026028421-A1 · Jan 29, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026098027-A1 · Apr 9, 2026 · US
US-2026055088-A1 · Feb 26, 2026 · US
US-12559539-B2 · Feb 24, 2026 · US
US-12559488-B2 · Feb 24, 2026 · US
US-2026028421-A1 · Jan 29, 2026 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 282 |
| Chemistry & Metallurgy | 278 |
| Physics | 29 |
| Cross-Sectional Technologies | 28 |
Answers are generated from the same data shown on this page.